Our staff at the Cancer Research Institute's headquarters in New York City hold special expertise in nonprofit management, medical communications, marketing and development, special event planning, and database administration. Each member of our team is passionate about the work we do and is committed to conquering cancer through immunotherapy.

CEO
Jill O'Donnell-Tormey, Ph.D.
Chief Executive Officer and Director of Scientific Affairs
Senior Staff
Brian M. Brewer
Director of Marketing and Communications
Lynne A. Harmer
Director of Grants Administration and Special Events
Vanessa M. Lucey, Ph.D., MBA
Director, CRI Venture Fund and Clinical Accelerator
Alfred R. Massidas
Chief Financial Officer and Director of Human Resources
Sharon Slade
Director of Strategic Initiatives
People
Arthur N. Brodsky, Ph.D.
Science Writer
Angela Bui
Strategic Initiatives Coordinator
Ryan Godfrey
Grants Administrator
Cierra Howard
Community Fundraising Coordinator
Rupinder Kaur
Senior Manager of Operations and Officer of Planned Giving
Marla S. Lawson
Associate Director of Corporate and Foundation Relations
Jasmine Lingard
Senior Manager of Special Events
Melinda Lopez
Receptionist and Community Fundraising Coordinator
Deanne Marbach
Development Officer
Katherine McCluskey
Project Coordinator
Shasell Negron
General Manager / Workplace Giving Campaign Manager
Alice Northover
Senior Marketing Manager
Caroline Offit
Associate Director of Patient Engagement
Laura Pearce, M.S.
Consultant, Head of Clinical Alliances
Alexa Schles
Graphic Designer
Devi Sharma
Donations Processing Manager
Jun Tang, Ph.D.
Senior Manager, CRI Venture Fund and Clinical Accelerator
Qing Hua Zhang
Controller
Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link

*Immunotherapy results may vary from patient to patient.

Contact Us

Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111

(800) 992-2623(212) 832-9376Staff Directory

Stay Connected with CRI

Follow us

Recent Blog Posts

CRI scientists Dr. Michele Ardolino and Dr. David Raulet showed that Natural Killer cells can help eliminate tumors after checkpoint immunotherapy treatment even in the absence of T cells.

The third installment of the Rational Combinations 360 conference, which will be held in Philadelphia September 13-14, seeks to improve the design and application of combination immunotherapies for patients
Top